drugset / Trial / NCT01224509
The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors
RandomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to determine the effect of mifepristone on the expression of three cervical EP3 receptor isoforms (EP3-2, EP3-3 and EP3-6) in pregnant women ≤63 days gestational age.
Timeline
- Start
- 2004-09
- Primary completion
- —
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mifepristone | Small molecule | 200 mg | Oral |
Indications
No indication recorded.